11/20/2008

PentaBase this week announced that it received $339,000 from an unnamed investor. The Danish company, which is developing diagnostic tools for influenza and bird flu, said it will use the funds to boost the sales of its platform technologies, services and diagnostic tests for infectious diseases.

Related Summaries